newsfilter
← Latest News
GlobeNewswire·

Azora Therapeutics Appoints Board of Directors with Extensive Drug Development and Inflammatory Bowel Disease Expertise

LOS ANGELES, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Azora Therapeutics, Inc. (NASDAQ:AZR), a biopharmaceutical company developing treatments for serious inflammatory diseases, today announced it has established a